Literature DB >> 15596173

State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Bob Djavan1, Chris Chapple, Shirin Milani, Michael Marberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15596173     DOI： 10.1016/j.urology.2004.07.031

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  38 in total

1.  [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

Authors:  K Höfner; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; T Bschleipfer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 2.  Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations.

Authors:  Gabriela Franco-Salinas; Jean J M C H de la Rosette; Martin C Michel
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

Review 3.  The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.

Authors:  Matt T Rosenberg; David Staskin; John Riley; Grannum Sant; Martin Miner
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

4.  Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

Review 5.  [Importance of adrenoceptor blockers and alpha reductase inhibitors : Monotherapy for treatment of benign prostate syndrome].

Authors:  F Strittmatter; S Madersbacher; C G Stief; C Gratzke
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

6.  Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study.

Authors:  Selçuk Altın; Tunç Ozan; Selçuk İlhan; Nevin İlhan; Rahmi Onur
Journal:  Turk J Urol       Date:  2015-09

7.  Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.

Authors: 
Journal:  Singapore Med J       Date:  2017-08       Impact factor: 1.858

8.  The effect of first dose of tamsulosin on flow rate and its predictive ability on the improvement of LUTS in men with BPH in the mid-term.

Authors:  Yigit Akin; Hakan Gulmez; Murat Ucar; Selcuk Yucel
Journal:  Int Urol Nephrol       Date:  2013-01-06       Impact factor: 2.370

9.  Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia.

Authors:  Kyoung Pyo Hong; Young Joon Byun; Hana Yoon; Young Yo Park; Woo Sik Chung
Journal:  Korean J Urol       Date:  2010-07-20

10.  Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration.

Authors:  K Kobayashi; N Masumori; R Kato; S Hisasue; R Furuya; T Tsukamoto
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.